Curtiss-Wright Corporation CW
Composite 52/100; the shares have moved about 37% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 29/100 — a moderate mark against it.
Balance-sheet strength ranks 65/100 — a moderate point in its favour. Growth ranks 63/100 — a moderate point in its favour. Quality ranks 57/100 — a slight point in its favour.
Valuation ranks 29/100 — a moderate mark against it. Income ranks 35/100 — a moderate mark against it. Momentum ranks 49/100 — a slight mark against it.
What the company does Curtiss-Wright Corporation (CW) designs and manufactures engineered products and services for aerospace, defense, nuclear power, and industrial markets. Its segments include Aerospace & Industrial, Defense Electronics, and Naval & Power, serving commercial and military aviation, power generation, and process industries.
Key financials CW reports strong profitability metrics: ROE 19.7%, ROA 8.6%, and ROCE 17.8%. Gross, operating, and net margins stand at 37.2%, 17.6%, and 14.2%, respectively. Revenue and EPS growth are 13.4% and 29.1%, with a Piotroski F-Score of 8/9 and Altman Z-score of 8.76, indicating robust financial health.
Stock health The stock shows mixed momentum: up 45.82% over 12 months but down 11.32% from its 52-week high. RSI(14) is 45.00, suggesting neutral technical positioning. Quality (64.6) and growth (65.9) scores are above average, but valuation (19.7) is a notable weak point.
Price vs fair value CW trades at a **PREMIUM of 56.60%** versus our fair-value estimate of 311.15 and at a **discount of 14.72%** to the analyst 12-month target of 822.17. - Recent headlines highlight defense/aerospace peers beating earnings, creating upward sentiment pressure (Zacks, 2026-07-27 to 2026-07-30). - CW’s own earnings expectations are framed positively ahead of its release (Zacks, 2026-07-29). - Analyst count of 6.0 supports the 822.17 target, implying potential upside from current levels.
Looking forward Forward P/E of 28.41 and PEG of 0.30 suggest valuation compression risk despite strong growth. High EV/EBITDA (34.86) and P/B (10.53) ratios indicate rich pricing. Focus on execution in Defense Electronics and Naval & Power segments to justify premium valuation.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.